Report: Branded Biopharms Most Exposed to Biosimilar Competition
March 8, 2014 - BioPharm International
In a new report on the global biosimilar drug
EMA Collaborates with HTA Assessment Networks
Gaining access to
February 22, 2014 - By: Sean Milmo BioPharm International
High technology assessments are having an impact on biosimilars development in Europe.
The Affordable Care Act's Impact on Innovation in Biopharma
February 22, 2014 - By: Jill E. Sackman, PhD, Rita E. Numerof, PhD, Michael Abrams BioPharm International
The biopharmaceutical industry contempla
Outsourcing Trends in Biopharmaceutical Manufacturing
February 18, 2014 - By: Eric Langer PHARMACEUTICAL TECHNOLOGY
Brazil Emerges as Global Biopharm Collaborator .
The phar
February 6, 2014 - By: Hellen Berger BioPharm International
Brazil is the first Latin American country to emerge as a global biopharmaceutical collaborator
Early Communication with Regulators is Essential for SMEs
January 27, 2014 - by: Sean Milmo, Pharmaceutical Technology
With SMEs gaining wider recognition as the powerhouse of research and innovation in Europe, regulatory agencies are urging companies to engage with regul
…
Predicting Progress in Protein Aggregation
January 27, 2014 - by: Cynthia Challener, PhD. Biopharm International
Techniques to enable the design and formulation of stable, protein-based therapeutics.
Determining Criticality, Part Two: DoE and Data-Driven Criticalit
January 27, 2014 - by: Mark Mitchell, Biopharm International
A practical roadmap in three parts that applies scientific knowledge, risk analysis, experimental data, and process monitoring throughout the three phases of the pro
…
Regulation of Biosimilars: A Matter of Variability, Similarity, a
January 19, 2014 - By: Sean Milmo BioPharm International
As the European Union takes a closer look at its biosimilars guidelines, some key issues are proving difficult to resolve.
Best Practices in Adopting Single-Use Systems
January 19, 2014 - By: John Schmitz BioPharm International